Elevated Insulin Can Reduce Effectiveness of PI3K Inhibitors - Rationale for Co-targeting the Insulin Receptor Family and PI3K

被引：1
|
作者：
Blouin, M. J. [1 ]
Zhao, Y. [1 ]
Birman, E. [1 ]
Pollak, M. [1 ]
机构：
[1] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada
来源：
EUROPEAN JOURNAL OF CANCER | 2012年 / 48卷
关键词：
D O I：
10.1016/S0959-8049(12)71284-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
636
引用
收藏
页码：S151 / S151
页数：1
相关论文
共 50 条
  • [1] Differential modulation of PI3K/Akt/mTOR activity by EGFR inhibitors: A rationale for co-targeting EGFR and PI3K in cisplatin-resistant HNSCC
    Liao, Jipei
    Yang, Zejia
    Abarzarzin, Shirin
    Cullen, Kevin J.
    Dan, Hancai
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2024, 46 (05): : 1126 - 1135
  • [2] Co-targeting PIM and PI3K/mTOR pathways with a single molecule: Novel orally available combined PIM/PI3K and PIM/PI3K/mTOR kinase inhibitors.
    Blanco Aparicio, Carmen
    Renner, Oliver
    Gomez-Casero, Elena
    Cebria, Antonio
    Ajenjo, Nuria
    Aguirre, Enara
    Cebrian, David
    Rodriguez de Miguel, Ma Carmen
    Pequeno, Belen
    Isabel Albarran, Ma
    Riesco, Rosario
    Belen Garcia, Ana
    Alvarez, Rosa
    O'Neill, Michael
    Martinez, Sonia
    Pastor, Joaquin
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [3] Co-Targeting PIM Kinase and PI3K/mTOR in NSCLC
    Moore, Gillian
    Lightner, Clara
    Elbai, Samira
    Brady, Lauren
    Nicholson, Siobhan
    Ryan, Ronan
    O'Sullivan, Katie E.
    O'Byrne, Kenneth J.
    Blanco-Aparicio, Carmen
    Cuffe, Sinead
    O'Neill, Michael
    Heavey, Susan
    Finn, Stephen P.
    Gately, Kathy
    CANCERS, 2021, 13 (09)
  • [4] Chemically targeting the PI3K family
    Knight, Z. A.
    Shokat, K. M.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2007, 35 : 245 - 249
  • [5] Novel inhibitors of the PI3K family
    Carnero, Amancio
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2009, 18 (09) : 1265 - 1277
  • [6] Targeting PI3K
    Cantley, L.
    Lewis, C. Cantley
    CANCER RESEARCH, 2012, 72
  • [7] Suppression of insulin feedback enhances the efficacy of PI3K inhibitors
    Hopkins, Benjamin D.
    Pauli, Chantal
    Xing, Du
    Wang, Diana G.
    Li, Xiang
    Wu, David
    Amadiume, Solomon C.
    Goncalves, Marcus D.
    Hodakoski, Cindy
    Lundquist, Mark R.
    Bareja, Rohan
    Ma, Yan
    Harris, Emily M.
    Sboner, Andrea
    Beltran, Himisha
    Rubin, Mark A.
    Mukherjee, Siddhartha
    Cantley, Lewis C.
    NATURE, 2018, 560 (7719) : 499 - +
  • [8] Suppression of insulin feedback enhances the efficacy of PI3K inhibitors
    Benjamin D. Hopkins
    Chantal Pauli
    Xing Du
    Diana G. Wang
    Xiang Li
    David Wu
    Solomon C. Amadiume
    Marcus D. Goncalves
    Cindy Hodakoski
    Mark R. Lundquist
    Rohan Bareja
    Yan Ma
    Emily M. Harris
    Andrea Sboner
    Himisha Beltran
    Mark A. Rubin
    Siddhartha Mukherjee
    Lewis C. Cantley
    Nature, 2018, 560 : 499 - 503
  • [9] Strategies for co-targeting the PI3K/AKT/mTOR pathway in NSCLC
    Heavey, Susan
    O'Byrne, Kenneth J.
    Gately, Kathy
    CANCER TREATMENT REVIEWS, 2014, 40 (03) : 445 - 456
  • [10] Co-targeting PI3K and ras pathways in trastuzumab resistance.
    Gray, Mike J.
    YangKolodji, Gloria Wangrong
    Tripathy, Debu
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345